28

Bioinformatics of the Brain

[21] F. A. C. Azevedo, L. R. Carvalho, L. T. Grinberg, et al., “Equal num-

bers of neuronal and nonneuronal cells make the human brain an iso-

metrically scaled‐up primate brain,” Journal of Comparative Neurology,

vol. 513, 2009.

[22] P. Wolfe, “Brain matters: Translating research into classroom practice,

2nd edition,” 2001.

[23] F. Uğur, “Evaluation of activities in secondary school level turkish work-

books according to types of memory and revised bloom’s taxonomy,”

International Education Studies, 2019.

[24] D. O. Hebb, “The role of neurological ideas in psychology,” Journal of

personality, vol. 20 1, pp. 39–55, 1951.

[25] P. W. Burgess and J. S. Simons, “Theories of frontal lobe executive

function: Clinical applications,” 2012.

[26] S. Dehaene, “Reading in the brain: The science and evolution of a human

invention,” 2009.

[27] B. E. Kolb, R. L. Gibb, and T. E. Robinson, “Brain plasticity and

behavior,” Current Directions in Psychological Science, vol. 12, pp. 1–5,

2003.

[28] R. L. Buckner and L. M. DiNicola, “The brain’s default network: up-

dated anatomy, physiology and evolving insights,” Nature Reviews Neu-

roscience, vol. 20, pp. 593–608, 2019.

[29] R. Hitzemann, P. Darakjian, N. A. R. Walter, et al., “Introduction to

sequencing the brain transcriptome.,” International review of neurobi-

ology, vol. 116, pp. 1–19, 2014.

[30] R. Daneman and A. Prat, “The blood-brain barrier,” Cold Spring Har-

bor perspectives in biology, vol. 7 1, p. a020412, 2015.

[31] M. I. Teixeira, C. M. Lopes, M. H. Amaral, et al., “Current insights

on lipid nanocarrier-assisted drug delivery in the treatment of neurode-

generative diseases.,” European journal of pharmaceutics and biophar-

maceutics: official journal of Arbeitsgemeinschaft fur Pharmazeutische

Verfahrenstechnik e.V, 2020.

[32] H. Scheiblich, M. I. Trombly, A. Ramírez, et al., “Neuroimmune connec-

tions in aging and neurodegenerative diseases,” Trends in immunology,

2020.

[33] T. Cassano, R. Villani, L. Pace, et al., “From cannabis sativa to

cannabidiol: Promising therapeutic candidate for the treatment of neu-

rodegenerative diseases,” Frontiers in Pharmacology, vol. 11, 2020.